CRG is a healthcare-focused investment firm that provides growth capital, primarily through long-term debt and equity, to commercial-stage companies in the biopharmaceutical, medical device, and healthcare services sectors. Their strategy involves offering flexible, minimally dilutive financing solutions and strategic support to help portfolio companies with product development, commercialization, and strategic growth initiatives.
67% of their portfolio is in Healthcare. Their most common stage is series-b (67% of deals). Average disclosed round size is $50.8M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$4B
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EEndoGastric Solutions | Series B | $30.5M | Jul 2018 |
 Earlens Corporation, Inc. | Series C | $73M | Jun 2017 |
 Intrinsic Therapeutics, Inc. | Series B | $49M | May 2017 |
Top Co-Investors
SightLine Partners2 shared
Advanced Technology Ventures1 shared
Canaan Partners1 shared
Chicago Ventures1 shared
Radius Capital1 shared
NEA (New Enterprise Associates)1 shared
Windham Venture Partners1 shared
Lightstone Ventures1 shared
Medtronic1 shared
Delos Capital1 shared
Greenspring Associates1 shared
Quadrille Capital1 shared
Last updated: 16 April 2026